Article
Practical comparison of 2.7 microm fused-core silica particles and porous sub-2 microm particles for fast separations in pharmaceutical process development.
Merck & Co., Inc., Rahway, NJ 07065, USA.
Journal of pharmaceutical and biomedical analysis (impact factor:
2.45).
08/2009;
51(1):131-7.
DOI:10.1016/j.jpba.2009.08.023
pp.131-7
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1.7 microm Acquity BEH C18
1.7 microm nonporous silica cores
1.8 microm Zorbax Eclipse
chromatographic parameters
fast HPLC separations
fused particles
fused-core column
fused-core particle column
fused-core particles
Fused-core silica stationary phases
HPLC impurity profiling
last point
low pressure
lower pressure
reduced intra-particle flow path
similar efficiency separations
sub-2 microm particle column
sub-2 microm particles
sub-2 microm porous particles
superior mass transfer kinetics